Table 5– Comparisons of baseline characteristics of patients who received corticosteroid treatment for 2 weeks and 4 weeks
Characteristics2 weeks4 weeksp-value
Subjects n8542
Age yrs20 (20–21)20 (20–21)0.863
History of allergic disease8 (10)3 (10)1.000
Time from initiation of smoking to presentation days#17 (14–28)16 (11–24)0.435
Symptoms
 Cough80 (94)40 (95)1.000
 Dyspnoea78 (92)41 (98)0.269
 Fever69 (81)41 (98)0.011
 Chill46 (54)26 (62)0.405
 Headache28 (33)11 (26)0.438
 Myalgia27 (32)3 (7)0.002
 Chest pain13 (15)5 (12)0.606
 Inspiratory crackle on chest auscultation53 (62)35 (83)0.016
Laboratory findings
 Leukocytosis >10000 cells·μL−159 (69)33 (79)0.277
 Peripheral eosinophilia >500 cells·μL−132 (38)8 (19)0.034
 C-reactive protein mg·dL−112.1 (5.9–31.4)35.6 (16.3–38.4)<0.001
Pa,O2/FI,O2 ratio298.7 (262.9–344.8)239.1 (219.3–268.8)<0.001
 Eosinophils on BAL %40 (35–53)40 (31–50)0.078
 Lymphocytes on BAL %19 (12–26)23 (12–30)0.747
 Neutrophil on BAL %5 (2–10)6 (4–17)0.004
  • Data are presented as median (interquartile range) or n (%), unless otherwise stated. Pa,O2: arterial oxygen tension: FI,O2: inspiratory oxygen fraction; BAL: bronchoalveolar lavage. #: data were available in 131 (97%) patients who were current smokers.